Biometrics Expertise for Clinical Trials and Regulatory Submissions
Every clinical development decision depends on data you can trust. Our biometrics experts combine scientific expertise with InStat™ technology to get you there faster.
Bringing therapies to patients requires clinical trial data that is properly designed, collected, and analyzed to demonstrate efficacy. To give you an advantage, Veristat has assembled an extraordinary team of scientific-minded biostatisticians, programmers, data managers and data standards experts, adaptive designsupported by InStat™, Veristat’s purpose-built biometrics technology platform, to bring greater speed, consistency, and efficiency to statistical analysis and reporting.
Integrated Biometrics Solutions Across the Development and Commercialization Lifecycle
Biometrics work doesn't just produce results, it reveals what your data is actually telling you early enough to act on it, not after a trial is already locked in a direction. That's what our biometrics team is built for.
InStat adds a powerful technology layer to that expertise. Built by biometrics experts for clinical development, InStat structures study data to regulatory standards and automates statistical analysis and reporting through validated statistical engines, while keeping experienced biostatisticians at the center of the work.
We bring biostatisticians, programmers, data managers, and data standards experts together under one roof: not siloed teams handing off work, but a group that thinks collectively about your program as a whole. That integrated team with expertise in adaptive trial design, together with InStat™ and you have a biometrics partner built to move efficiently from data to analysis to decision.
The result: Data you can trust, insight you can act on, and a clearer path to your next decision.
HOW IT WORKS
Your data moves through several critical stages between enrollment and final submission.
Our biometrics team supports you at every step.
Build and manage your data
We design, build, and deploy your clinical trial database, capturing clean, reliable data from day one.
Program your datasets
Our statistical programmers transform raw trial data into accurate, analysis-ready datasets. InStat brings automation and standardization into the process, helping accelerate the path from study data to analysis-ready outputs.
Analyze and interpret
Our biostatisticians combine scientific expertise with InStat technology to accelerate statistical analysis and reporting, helping you understand what your data means for your program’s next decision.
Standardize for submission
We prepare your data into SDTM and ADaM formats, submission-ready for regulatory agencies around the world, with InStat supporting a structured, traceable path toward submission-ready deliverables.
Monitor for safety, throughout
Independent Data Monitoring Committees provide ongoing oversight, protecting patient safety and reducing risk across the life of your trial.
Scale with the right team
Through our FSP and resourcing model, we flex to meet your program's milestones, whenever and wherever you need us.
Proof Points
Lorem ipsum headline
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Therapeutic nuance, not templates
Fluent in plain language
Built for complexity
Scalable by design
Expertise amplified by technology
InStat™ combines automation with expert biostatistician oversight to accelerate analysis without sacrificing scientific rigor.
Veristat's Offerings
Every one of these services is backed by hands-on experience in the areas that matter most: adaptive designs, rare disease and small populations, complex biologics data, and independent safety oversight, delivered at the speed your program needs.
Data Management
Accelerating the design, build, and deployment of clinical trial databases faster than the industry norm.
Expert statistical planning and analysis, strengthened by InStat technology, to move efficiently from study data to reliable results and development decisions.
Purpose-built biometrics technology that combines specification-driven automation, validated statistical engines, and expert oversight to accelerate statistical analysis and reporting.
Move from data and documentation to a fully coordinated submission.
Agency Meetings
Prepare to present your data and development plan directly to regulators.
Adaptive Designs
Build flexibility into your trial design using simulation and biostatistics expertise.
Marketing Applications
Take your submission-ready data through to approval.
PROOF & RESOURCES
Perspectives on Complex Clinical Development
Explore perspectives from Veristat experts on clinical trial design and execution, regulatory strategy, biometrics, rare disease, oncology, cell and gene therapy, and other challenges shaping Phase I–IV development.
Make the evidence behind your program work harder and smarter.
The right regulatory strategy starts with knowing what your data can tell you, and what it means for what comes next. Veristat brings regulatory, clinical, statistical, CMC, and scientific expertise together to turn your evidence into a clear development direction and the decisions that move your program toward its next milestone.
In clinical research, biometrics refers to the biostatistics, data management, statistical programming, and data standards work that supports a trial, not the fingerprint or facial recognition technology the term is often associated with elsewhere.
Data management focuses on collecting, cleaning, and organizing clinical trial data through database design and quality control, while biostatistics focuses on analyzing that data to answer the trial's scientific and regulatory questions.
SDTM (Study Data Tabulation Model) and ADaM (Analysis Data Model) are industry-standard data structures required by regulatory agencies like the FDA. Formatting trial data into these standards is what makes a submission's data package usable and reviewable by regulators.
FSP (Functional Service Provider) is a flexible staffing model where a sponsor engages dedicated biometrics experts, such as programmers or biostatisticians, to integrate directly into their team, rather than outsourcing an entire function. It's often used when a sponsor needs to scale specific expertise quickly without building out a full internal department.
A DMC is an independent group that periodically reviews accumulating trial data, often unblinded, to monitor patient safety and trial integrity. It provides an added layer of oversight that helps protect patients while maintaining the statistical validity of the trial.
An internal team can absolutely handle much of this work, and this doesn't have to be all-or-nothing. Outside biometrics support tends to add the most value at specific pressure points, ahead of a major submission deadline, during a data standardization backlog, or when a program needs specialized DMC or FSP support beyond your team's current bandwidth. Bringing in targeted expertise at those moments helps protect your timeline without requiring a handoff of the whole function.
InStat™ is Veristat’s purpose-built biometrics technology platform, developed to accelerate statistical analysis and reporting while maintaining the rigor required for clinical development and regulatory submissions. It combines specification-driven automation and validated statistical engines with expert biostatistician review, creating reproducible and traceable outputs while allowing Veristat’s experts to focus more of their time on the scientific and statistical questions that matter.
